Advanced, Androgen Receptor Positive Triple Negative Breast Cancer
1 competing product in clinical development for Advanced, Androgen Receptor Positive Triple Negative Breast Cancer.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Enzalutamide | Astellas Pharma | Phase 2 | Completed | 35 |